$LDRH (LDR Holding Corporation)

$LDRH {{ '2016-06-08T12:12:59+0000' | timeago}} • Announcement

Rigrodsky & Long P.A. said it is investigating potential legal claims against BoD of $LDRH regarding possible breaches of fiduciary duties and other violations of law related to the company's entry into an agreement to be acquired by $ZBH for about $1Bil. The investigation concerns on failure by $LDRH's BoD to obtain best possible value.

$ISRG {{ '2017-10-19T21:40:26+0000' | timeago}} • Announcement

Worldwide da Vinci procedures grew approx. 15% in 3Q17 as $ISRG shipped 169 da Vinci Surgical Systems during the quarter. With $TRXC already in its sight, Intuitive Surgical will also be eyeing $MDT with much more concern as Medtronic is set to roll out its surgical robot system next year.

$ISRG {{ '2017-10-19T21:22:14+0000' | timeago}} • Announcement

Amidst concern over an emerging competition for its da Vinci Surgical Systems, $ISRG posted its 3Q17 results where revenue increased 18% and profit grew 41%. Recently, the US FDA has shown the green light for $TRXC to market its Senhance Surgical Robotic System, the first system since 2010 to compete head-to-head against $ISRG's da Vinci system.

$NUVA {{ '2017-10-19T12:36:06+0000' | timeago}} • Announcement

$NUVA announced the launch of Modulus XLIF titanium implants. The new Modulus titanium implants are developed using additive manufacturing technology, or 3D printing, to create an organic, porous architecture that mimics the porosity and stiffness of bone for reduced stress shielding.

$MDXG {{ '2017-10-17T15:58:07+0000' | timeago}} • Announcement

$MDXG warned that certain individuals or entities not associated with the company are establishing fake email accounts to impersonate company executives. The company warns that emails purporting to be from $MDXG executives from non-MiMedx email accounts should be viewed sceptically and brought to its notice. The issue is being investigated.

$MDXG {{ '2017-10-17T12:38:30+0000' | timeago}} • Announcement

$MDXG, a pharmaceutical firm, said it received green signal from the FDA to proceed with the Investigational New Drug study of AmnioFix, an injectable formulation for  the treatment of knee osteoarthritis, in comparison with saline placebo. The company expects patient enrollment in the the phase-2B study to commence next quarter.

$MDT {{ '2017-10-16T20:09:05+0000' | timeago}} • Announcement

$MDT said its Medtronic Care Management Services (MCMS) business and American Well entered into a strategic partnership. Under the agreement, the businesses will work together to enable patient access to American Well's telemedicine services on MCMS' video-enabled platforms, and to allow bi-directional data flow between the two parties.

$NUVA {{ '2017-10-16T13:28:28+0000' | timeago}} • Announcement

$NUVA has received an expanded FDA 510(k) clearance of its TLX interbody system, used in spinal fusion surgery. New clearance introduces an expandable 20 degree cage and broader indications for use.

$BAX {{ '2017-10-12T20:41:03+0000' | timeago}} • Announcement

$BAX provided updates regarding recovery efforts following the impact of Hurricane Maria on its Puerto Rico operations. While $BAX now anticipates a reduction in revenue for 4Q17 as a result of the storm, the company expects to mitigate the related earnings impact through positive performance in other areas of the business.

$MDXG {{ '2017-10-10T14:24:36+0000' | timeago}} • Announcement

$MDXG announced its preliminary revenue results for 3Q17. The company recorded revenue of $84.6MM, up 31% over 3Q16. Revenue from the direct sales force is in excess of 95% of total revenue with revenue from distributors and Original Equipment Manufacturer (OEM) accounts below 5% of total revenue. YTD revenue grew 33% to $233.6MM vs. last year.

$MDXG {{ '2017-10-09T12:45:46+0000' | timeago}} • Announcement

$MDXG's BoD has authorized a $10MM increase in the company's share repurchase program, bringing the total authorized to $110MM since the commencement in May 2014.

$JNJ {{ '2017-10-05T13:58:49+0000' | timeago}} • Announcement

Animas Corp., a $JNJ Diabetes Care Companies, plans to discontinue the manufacturing and sale of Animas Vibe and OneTouch Ping insulin pumps, close operations and exit the insulin pump business. Animas has selected $MDT as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers.

$HRC {{ '2017-10-05T12:06:47+0000' | timeago}} • Announcement

Chairman of $HRC Board Rolf Classon will not stand for re-election to the BoD when his current term expires on March 6, 2018. The Board plans to appoint current independent director William Dempsey to this role if he is re-elected by shareholders. The company also elected Gary Ellis, retired CFO and SVP of $MDT, to its BoD, effective Oct 5, 2017.

$MDXG {{ '2017-10-04T15:20:48+0000' | timeago}} • Announcement

$MDXG and one of its employees have filed a lawsuit against Viceroy Research and Sparrow Fund Research LP a/k/a Aurelius Value, John Fichthorn, BR Dialectic Capital Management, LLC, and "Does" 1-10, for libel, slander, defamation, false light, and tortious interference with business relations.

$MDXG {{ '2017-10-03T15:04:14+0000' | timeago}} • Announcement

$MDXG appointed Gloria Matthews as its SVP, Research and Development. Matthews will lead the company's overall research function as well as the development of new products. The company also reaffirmed its previously communicated revenue expectations for 3Q17.

$BAX {{ '2017-10-03T14:37:28+0000' | timeago}} • Announcement

$BAX announced enrollment of first patients in two new clinical trials for a unique expanded hemodialysis (HDx) therapy enabled by Theranova. Baxter’s HDx therapy enabled by Theranova was designed to remove large molecular weight toxins that have been associated with inflammation and cardiovascular health for end-stage renal disease patients.

$MDXG {{ '2017-10-02T18:55:33+0000' | timeago}} • Announcement

$MDXG divested its subsidiary, Stability Biologics LLC back to the former stockholders of Stability Inc. The transaction closed on Sept. 30, 2017. The consideration included a promissory note issued by Stability Biologics for $3.5MM and a waiver of all claims and rights to any earn-out consideration. $MDXG expects to book a one-time gain.

$MDXG {{ '2017-10-02T14:00:41+0000' | timeago}} • Announcement

$MDXG said Northern District Court of Georgia has set a trial date of Jan. 22, 2018 for the company's patent infringement lawsuit against Musculoskeletal Transplant Foundation, Medline Industries, and Liventa Bioscience.

$AMAG {{ '2017-09-29T12:41:24+0000' | timeago}} • Announcement

$AMAG announced the appointment of Tracy Palmer Berns as Chief Compliance Officer, with immediate effect. She will report to Joseph Vittiglio, General Counsel and SVP of Legal Affairs and Quality. Berns was the VP of Ethics and Compliance at the Minimally Invasive Therapies Group at $MDT.

$MDXG {{ '2017-09-19T15:22:20+0000' | timeago}} • Announcement

$MDXG has filed with the FDA to initiate its Investigational New Drug (IND) Phase 2 clinical trial for osteoarthritis of the knee. The objective is to determine the safety and effectiveness of AmnioFix Injectable as compared to the 0.9% Sodium Chloride USP placebo injection control for the treatment of knee osteoarthritic pain.

$MDT {{ '2017-09-18T13:29:52+0000' | timeago}} • Announcement

$MDT announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow.

Recent Transcripts

MGCD (MGC Diagnostics Corporation)
Wednesday, September 6 2017 - 8:30pm
MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
XTNT (Xtant Medical Holdings, Inc.)
Thursday, August 10 2017 - 2:00pm
OMER (Omeros Corporation)
Tuesday, August 8 2017 - 8:30pm
RTIX (RTI Surgical Inc.)
Tuesday, August 8 2017 - 12:30pm
OFIX (Orthofix International N.V.)
Monday, August 7 2017 - 8:30pm
GMED (Globus Medical, Inc.)
Wednesday, August 2 2017 - 9:30pm
OSUR (OraSure Technologies, Inc.)
Wednesday, August 2 2017 - 9:00pm
WMGI (Wright Medical Group N.V.)
Wednesday, August 2 2017 - 8:30pm
OMED (OncoMed Pharmaceuticals, Inc.)
Wednesday, August 2 2017 - 8:30pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
EXAC (Exactech Inc.)
Friday, July 28 2017 - 2:00pm
NUVA (NuVasive, Inc.)
Thursday, July 27 2017 - 8:30pm
SYK (Stryker Corporation)
Thursday, July 27 2017 - 8:30pm
MDXG (MiMedx Group, Inc.)
Thursday, July 27 2017 - 2:30pm
ZBH (Zimmer Biomet Holdings, Inc.)
Thursday, July 27 2017 - 12:00pm
BAX (Baxter International Inc.)
Wednesday, July 26 2017 - 12:30pm
OPHT (Ophthotech Corporation)
Wednesday, July 26 2017 - 12:00pm
NURO (NeuroMetrix Inc.)
Thursday, July 20 2017 - 12:00pm
MGCD (MGC Diagnostics Corporation)
Thursday, June 1 2017 - 8:30pm

AlphaGraphics you may like